JPMorgan Sees 35% Odds of Recession, Eli Lilly Stock Leaps on Strong Demand for Weight-Loss Drugs

The Rundown - JPMorgan Sees 35% Odds of Recession, Eli Lilly Stock Leaps on Strong Demand for Weight-Loss Drugs